Mednet Logo
HomeQuestion

Have you used itraconazole as a primary or adjunct therapy for individuals with numerous BCCs?

2 Answers
Mednet Member
Mednet Member
Medical Oncology · The Ohio State University Comprehensive Cancer Center

Yes. I use itraconazole 100 mg daily with sonidegib 200 mg (daily or less frequently, depending on tolerance, but no less than twice a week) in every patient who shows a resistant SMO mutation on an NGS panel.

I test all patients at baseline and at recurrence to determine what treatment to offer.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Dermatology · Wake Forest University

No, for these patients, I have found vismodegib or sonidegib works best. Most cannot tolerate the daily dosing for long, and we cycle the medication usually taking it the first 10 days of the month, then off the rest of the month.

Register or Sign In to see full answer

Have you used itraconazole as a primary or adjunct therapy for individuals with numerous BCCs? | Mednet